Sugi Predict

Sugi Predict / Compounds / Psoralen

Psoralen

Psoralen

SCHEMBL3647286

N.O=c1ccc2cc3ccoc3cc2o1

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 6/20 0.96
▸ CYP3A4 P08684 5/20 0.96
▸ ACHE P22303 4/20 0.96
▸ KDM4E B2RXH2 4/20 0.96
▸ HSD17B10 Q99714 4/20 0.96
▸ CYP2A6 P11509 4/20 0.96
▸ CYP2D6 P10635 3/20 0.96
▸ CYP2C19 P33261 3/20 0.96
▸ NFKB1 P19838 2/20 0.96
▸ CYP2C9 P11712 2/20 0.96
▸ GAA P10253 3/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ MGAM O43451 1/20 0.54
▸ SI P14410 1/20 0.54
▸ PTPN1 P18031 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ MGAM2 Q2M2H8 1/20 0.54
▸ ALDH1A1 P00352 5/20 0.53
▸ MCL1 Q07820 5/20 0.53
▸ CA12 O43570 5/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Psoralen SCHEMBL2684633 0.98 MAOA (1.00) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL17835 0.98 MAOA (1.00) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL29503678 0.98 MAOA (1.00) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL8707426 0.96 MAOA (0.96) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL27405230 0.96 MAOA (0.96) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL28036058 0.96 MAOA (0.96) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL29165499 0.96 MAOA (0.96) MAOACYP3A4ACHEKDM4EHSD17B10
SCHEMBL11458294 0.92 HSD17B10 (0.89) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL4264885 0.91 MAOA (0.86) MAOACYP3A4ACHEKDM4EHSD17B10
Psoralen SCHEMBL4376218 0.91 MAOA (0.86) MAOACYP3A4ACHEKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107298686-B A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2018-10-26 — — CN claimed
CN-107298686-A A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2017-10-27 — — CN claimed
EP-0840781-B1 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS CERUS CORP (US) 2009-12-09 — — EP claimed
EP-0840781-A4 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS CERUS CORP (US) 2001-03-21 — — EP claimed
EP-0840781-A1 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS Cerus Corporation (US) 1998-05-13 — — EP claimed
WO-1996040857-A1 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS CERUS CORPORATION (US) 1996-12-19 — — WO claimed
CN-107814809-B A kind of psoralen derivative and purposes of the triazole containing phenyl 中国科学院新疆理化技术研究所 2019-07-19 — — CN disclosed
CN-107298686-B A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2018-10-26 — — CN disclosed
CN-107298686-B A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2018-10-26 — — CN disclosed
CN-107298686-B A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2018-10-26 — — CN disclosed
CN-107814809-A The psoralen derivative and purposes of a kind of triazole containing phenyl 中国科学院新疆理化技术研究所 2018-03-20 — — CN disclosed
CN-107298686-A A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2017-10-27 — — CN disclosed
CN-107298686-A A kind of psoralen amine derivant and purposes 中国科学院新疆理化技术研究所 2017-10-27 — — CN disclosed
US-20050153913-A1 Nucleic acid carrier compositions and methods for their synthesis KOSAK KENNETH M (US) 2005-07-14 — — US disclosed
US-6544727-B1 Deactivating nucleic acid pathogens CERUS CORPORATION 2003-04-08 — — US disclosed
US-20020192632-A1 Method and devices for the removal of psoralens from blood products HEI DEREK J (US) 2002-12-19 — — US disclosed
US-20020115585-A1 Method and devices for the removal of psoralens from blood products HEI DEREK J (US) 2002-08-22 — — US disclosed
EP-0840781-A4 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS CERUS CORP (US) 2001-03-21 — — EP disclosed
EP-0840781-A1 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS Cerus Corporation (US) 1998-05-13 — — EP disclosed
WO-1996040857-A1 METHODS AND DEVICES FOR THE REMOVAL OF PSORALENS FROM BLOOD PRODUCTS CERUS CORPORATION (US) 1996-12-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115585-A1 Method and devices for the removal of psoralens from blood products SERPINB10, RAD50, F2 MAOA 2515/4885CYP3A4 2116/4885ACHE 3081/4885
US-20050153913-A1 Nucleic acid carrier compositions and methods for their synthesis DNA2, POLRMT, SLC29A2 MAOA 3441/4885CYP3A4 3796/4885ACHE 3169/4885
US-20020192632-A1 Method and devices for the removal of psoralens from blood products PLG, SERPINB10, RAD50 MAOA 2207/4885CYP3A4 1368/4885ACHE 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.